New peritoneal dialysis fluids: Practical use for children

Pediatric Nephrology

Volumn 18, Issue 11, 2003, Pages 1085-1088

  Schröder, Cornelis H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bicarbonate; Calcium; Icodextrin; Peritoneal dialysis solutions

Indexed keywords

BICARBONATE; BUFFER; CALCIUM; ICODEXTRIN; LACTIC ACID; OSMOTIC AGENT; PERITONEAL DIALYSIS FLUID; PHOSPHATE BINDING AGENT; VITAMIN D DERIVATIVE;

AGE DISTRIBUTION; CALCIUM BALANCE; CHILD UROLOGY; CLINICAL PRACTICE; DIALYSATE; EDITORIAL; HUMAN; HYPOCALCEMIA; KIDNEY CLEARANCE; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PH MEASUREMENT; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SKIN ALLERGY; ULTRAFILTRATION;

BUFFERS; CALCIUM; CHILD; DIALYSIS SOLUTIONS; HUMANS; OSMOSIS; PERITONEAL DIALYSIS;

EID: 0242441930     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1307-x     Document Type: Editorial

References (36)

1. Krediet RT, Zweers MM, Ho-dac-Pannekeet MM, Van der Wal AC, Smit W, Douma CE, Mateijsen MAM, Struijk DG (1999) The effect of various dialysis solutions on peritoneal membrane viability. Perit Dial Int [Suppl 2] 19:257-266
2. Lameire N, Van Biesen W, Vanholder R (1998) Consequences of using glucose in peritoneal dialysis fluid. Semin Dial 11: 271-275
3. Raj DSC, Choudhury D, Welbourne TC, Levi M (2000) Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 35:365-380
4. Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, Wrege U, Gröntoft K-C, Larsson R, Berglund J, Tranaeus AP, Faict D (1998) Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 53:1061-1067
5. Schröder CH, Van Dreumel MJ, Reddingius R, Theeuwes AGM, Willems HL, De Jong MCJW, Monnens LAH (1992) Peritoneal transport kinetics of glucose, urea, and creatinine during infancy and childhood. Perit Dial Int 12:322-325
6. Warady BA, Alexander SR, Hossli S, Vonesh E, Geary D, Watkins S, Salusky IB, Kohaut EC (1996) Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 7:2385-2391
7. Günal AI, Celiker H, Akpolat N, Üstündag B, Duman S, Akcicek F (2002) By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution. Perit Dial Int 22:301-306
8. Jones MR (1995) Intraperitoneal amino acids: a therapy whose time has come? Perit Dial Int [Suppl 5] 15:67-74
9. Canepa A, Verrina E, Perfumo F, Carrea A, Menoni S, Delucchi P, Gusmano R (1999) Value of intraperitoneal amino acids in children treated with chronic peritoneal dialysis. Perit Dial Int [Suppl 2] 19:435-440
10. Kopple JD, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, Stegink LD, Martis L, Boyle CA, Serkes KD, Vonesh E, Jones MR (1995) Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 47:1148-1157
11. Jones M, Hagen T, Boyle CA, Vonesh E, Hamburger R, Charytan C, Sandroni S, Bernard D, Piraino B, Schreiber M, Gehr T, Fein P, Friedlander M, Burkart J, Ross D, Zimmerman S, Swartz R, Knight T, Kraus A, McDonald L, Hartnett M, Weaver M, Mattis L, Moran J (1998) Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis 32:761-769
12. Bajo MA, Selgas R, Del Peso G, Castro MJ, Hevia C, Gil F, Costero O, Olea T, Jimenez C (2002) Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions. Nefrologia 22: 348-355
13. De Boer AW, Schröder CH, Van Vliet R, Willems JL, Monnens LAH (2000) Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism. Pediatr Nephrol 15: 21-24
14. Mistry CD, Gokal R, Peers E, MIDAS Study Group (1994) A randomized clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 46:496-503
15. Posthuma N, Ter Wee PM, Donker AJM, Oe PL, Van Dorp W, Peers EM, Verbrugh HA (1997) Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Perit Dial Int 17:602-607
16. Rusthoven E, Krediet RT, Willems JL, Monnens LAH, Schröder CH (2001) Peritoneal transport characteristics with icodextrin based dialysate in children (abstract). Perit Dial Int [Suppl 2] 21:151
17. Wolfson M, Ogrinc F, Mujais S (2002) Review of clinical trial experience with icodextrin. Kidney Int [Suppl 81] 62:46-52
18. Boer WH, Vos PF, Fieren MWJA (2003) Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis. Perit Dial Int 23:33-38
19. Gokal R (2002) Icodextrin-associated sterile peritonitis. Perit Dial Int 22:445-448
20. Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Böswald M, Klaus G, Passlick-Deetjen J, Schaefer F (2002) Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Kidney Int 61:1527-1536
21. Topley N, Kaur D, Petersen MM, Jörres A, Williams JD, Faict D, Holmes CJ (1996) In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 7:218-224
22. Jörres A, Bender TO, Finn A, Witowski J, Fröhlich S, Gahl GM, Frei U, Keck H, Passlick-Deetjen J (1998) Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 54:2184-2193
23. Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, Faict D, Topley N (2002) Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 13:97-103
24. Mortier S, De Vriese AS, McLoughlin RM, Topley N, Schaub TP, Passlick-Deetjen J, Lameire NH (2003) Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 14: 1296-1306
25. Zeier M, Schwenger V, Deppish R, Hang U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E (2003) Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 63:298-305
26. Schmitt CP, Von Heyl D, Haas S, Mehls O, Schaefer F (2003) Peritoneal dialysis (PD) solution with reduced glucose degradation product (GDP) content lowers serum concentrations of advanced glycated endproducts (AGE) in children on automated PD (abstract). Nephrol Dial Transplant [Suppl 4] 18:210-211
27. Feriani M, Kirchgessner J, La Greca G, Passlick-Deetjen J (1998) Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 54:1731-1738
28. Tranaeus A, for the Bicarbonate/Lactate Study Group (2000) A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - clinical benefits. Perit Dial Int 20:516-523
29. Otte K, Gonzalez MT, Bajo M-A, Del Peso G, Heaf J, Erauzkin GG, Tomero JAS, Dieperink H, Povlsen J, Hopwood AM, Divino Filho JC, Faict D (2003) Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int 23:138-145
30. Haas S, Schmitt CP, Bonzel KE, Pieper AK, Fischbach M, John U, Arbeiter K, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F (2003) Improved acidosis correction and recovery of mesothelial cell mass by pH neutral bicarbonate dialysis solution in children on automated peritoneal dialysis. J Am Soc Nephrol (in press)
31. Fischbach M, Terzic J, Chauvé S, Laugel V, Muller A, Haraldsson B (2003) In children, the peritoneal area available for exchange is influenced by the composition of the peritoneal dialysis fluid. Nephrol Dial Transplant (in press)
32. Weinreich T, Ritz E, Passlick-Deetjen J (1996) Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Perit Dial Int 16:260-268
33. Rippe B, Levin L (1998) Should dialysate calcium be varied in proportion to the amount of ultrafiltration in peritoneal dialysis dwells? Directions from a computer simulation. Perit Dial Int 18:474-477
34. 2+ and glucose concentrations. Kidney Int 64:208-215
35. Brandi L, Nielsen PK, Bro S, Daugaard H, Olgaard K (1998) Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol/L) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis. J Intern Med 244:121-131
36. Schröder CH, on behalf of the European Paediatric Peritoneal Dialysis Working Group (EPPWG) (2001) The choice of dialysis solutions in pediatric chronic peritoneal dialysis: guidelines by an ad hoc European committee. Perit Dial Int 21: 568-574